Trials / Recruiting
RecruitingNCT07021963
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
A Multicenter, Open-label Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study mainly evaluates the long-term safety of HRS-1893 in subjects with hypertrophic cardiomyopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1893 Tablet | HRS-1893 tablet. |
Timeline
- Start date
- 2025-07-04
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2025-06-15
- Last updated
- 2025-09-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07021963. Inclusion in this directory is not an endorsement.